DJO Surgical and the University of Utah have signed a license agreement that will enable DJO Surgical to develop a percutaneous osseointegrated prosthesis for above-the-knee amputees. Percutaneous osseointegrated prosthesis involves an implant in the femur that protrudes through the skin and attaches to a prosthetic limb. University of Utah researchers have developed a device using DJO Surgical's new proprietary titanium P-squared porous coating.
Backed by an animal study involving over 80 sheep implanted with this device, no infections were found after one year and the implant showed mechanical strength. Development work on the human implant has already started, and clinical trials are expected to begin in approximately two years. The initial trial sites are expected to be within the VA system, and most of the patients are expected to be war veteran amputees.
Backed by an animal study involving over 80 sheep implanted with this device, no infections were found after one year and the implant showed mechanical strength. Development work on the human implant has already started, and clinical trials are expected to begin in approximately two years. The initial trial sites are expected to be within the VA system, and most of the patients are expected to be war veteran amputees.
More Articles on Orthopedic Devices:
Minimally Invasive Surgery Market to Reach $35.5B by 2016
MiMedx Revenues Reach $4.9M in 2Q, 153% Increase
China Device Market Expected Grew at 20.5% CAGR From 2006-2011